Alliqua Inc (ALQA) 6.14 $ALQA
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals
PR Newswire - Thu Feb 12, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.34 (unch), AFAM: 30.88 (+0.37), ALNY: 95.54 (+1.67), AMAG: 41.49 (+0.23), ALQA: 6.14 (+0.09)
Alliqua Biomedical: An Attractive Opportunity In The Wound Care Space
Kanak Kanti De - at Seeking Alpha - Tue Feb 10, 10:19AM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2014 Results on February 24th
GlobeNewswire - Tue Feb 10, 6:29AM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced plans to release fourth quarter and fiscal year 2014 financial results before the market opens on February 24th.
ALQA: 6.14 (+0.09)
Nasdaq stocks posting largest percentage increases
AP - Thu Feb 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
EOPN: 8.55 (-0.01), HPJ: 5.71 (+0.16), GLUU: 5.12 (+0.14), BPFH: 13.08 (+0.22), TLOG: 5.12 (+0.36), SOFO: 8.07 (-0.16), EGLT: 10.60 (+0.58), BBSI: 39.78 (+0.84), SLAB: 49.26 (-0.27), CONN: 24.69 (-0.07), CBMG: 24.32 (-1.17), ALQA: 6.14 (+0.09), LWAY: 19.83 (+0.11)
Alliqua BioMed buys Minnesota medical device firm
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:58PM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. to Acquire Celleration, Inc.
GlobeNewswire - Mon Feb 02, 3:01PM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products, today announced that it has signed a definitive agreement to acquire Celleration, Inc. ("Celleration" for an initial purchase price of approximately $30.4 million, which is comprised of both cash and stock. The merger agreement provides for additional contingent payments in stock and cash, under certain circumstances, if stated revenue thresholds are reached over the next two years ending December 31, 2016 or if certain milestones are satisfied in connection with product sales in the U.K.
ALQA: 6.14 (+0.09)
Alliqua Bio inks purchasing deal with Premier
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 7:56AM CST
ALQA: 6.14 (+0.09)
Strength Seen in Alliqua (ALQA): Stock Up 13.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 8:39AM CST
Alliqua, Inc. (ALQA) was a big mover last session, as the company saw its shares rise over 13% on the day.
ACOR: 36.14 (-0.51), ALQA: 6.14 (+0.09)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 16.82 (+0.17), HBNK: 21.40 (+0.25), BRDR: 6.15 (+0.04), SAPE: 24.98 (-0.02), TAIT: 1.03 (+0.03), BASI: 2.06 (+0.18), GERN: 3.03 (unch), NYMX: 0.36 (-0.02), MTEX: 23.89 (+0.69), CKEC: 29.96 (+0.89), ALQA: 6.14 (+0.09)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 7.65 (+0.09), NEO: 4.10 (unch), AU: 12.33 (+0.36), FNHC: 29.64 (-0.29), AMS: 2.48 (+0.06), NYMX: 0.36 (-0.02), AMDA: 0.65 (+0.01), CVD: 107.08 (+0.05), GBIM: 7.85 (+0.25), RCAP: 10.28 (+0.28), KBIO: 0.45 (+0.06), COOL: 1.19 (unch), SAPE: 24.98 (-0.02), XTLB: 2.08 (-0.04), GERN: 3.03 (unch), ANIP: 62.69 (-0.43), BBLU: 1.26 (+0.09), NXTD: 2.70 (+0.04), AP: 18.27 (+0.09), ALQA: 6.14 (+0.09)
Alliqua's Biovance gets additional reimbursement code
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:54AM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc.'s Biovance(R) Assigned Level II HCPCS Q Code for Product Reimbursement
GlobeNewswire - Mon Nov 03, 6:30AM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products, today announced that Alliqua's Biovance(R) Human Amniotic Membrane Allograft, has been assigned a new and unique, Level II Healthcare Common Procedure Coding System (HCPCS) product reimbursement Q code (Q4154) by the Centers for Medicare and Medicaid Services ("CMS" . The new Q code assignment for Biovance is reflected in the Hospital Outpatient Prospective Payment System Final Rule for CY 2015, released by CMS on October 31, 2014. The new reimbursement code takes effect on January 1, 2015.
ALQA: 6.14 (+0.09)
More on Alliqua BioMedical Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 4:16PM CDT
ALQA: 6.14 (+0.09)
Alliqua's (ALQA) CEO David Johnson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55PM CDT
ALQA: 6.14 (+0.09)
Alliqua misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:06PM CDT
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 30, 3:49PM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products, today announced financial results for the third quarter ended September 30, 2014.
ALQA: 6.14 (+0.09)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals
PR Newswire - Thu Feb 12, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.34 (unch), AFAM: 30.88 (+0.37), ALNY: 95.54 (+1.67), AMAG: 41.49 (+0.23), ALQA: 6.14 (+0.09)
Alliqua Biomedical: An Attractive Opportunity In The Wound Care Space
Kanak Kanti De - at Seeking Alpha - Tue Feb 10, 10:19AM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. to Announce Fourth Quarter and Fiscal Year 2014 Results on February 24th
GlobeNewswire - Tue Feb 10, 6:29AM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced plans to release fourth quarter and fiscal year 2014 financial results before the market opens on February 24th. ALQA: 6.14 (+0.09)
Nasdaq stocks posting largest percentage increases
AP - Thu Feb 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
EOPN: 8.55 (-0.01), HPJ: 5.71 (+0.16), GLUU: 5.12 (+0.14), BPFH: 13.08 (+0.22), TLOG: 5.12 (+0.36), SOFO: 8.07 (-0.16), EGLT: 10.60 (+0.58), BBSI: 39.78 (+0.84), SLAB: 49.26 (-0.27), CONN: 24.69 (-0.07), CBMG: 24.32 (-1.17), ALQA: 6.14 (+0.09), LWAY: 19.83 (+0.11)
Alliqua BioMed buys Minnesota medical device firm
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:58PM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. to Acquire Celleration, Inc.
GlobeNewswire - Mon Feb 02, 3:01PM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced that it has signed a definitive agreement to acquire Celleration, Inc. ("Celleration" for an initial purchase price of approximately $30.4 million, which is comprised of both cash and stock. The merger agreement provides for additional contingent payments in stock and cash, under certain circumstances, if stated revenue thresholds are reached over the next two years ending December 31, 2016 or if certain milestones are satisfied in connection with product sales in the U.K. ALQA: 6.14 (+0.09)
Alliqua Bio inks purchasing deal with Premier
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 7:56AM CST
ALQA: 6.14 (+0.09)
Strength Seen in Alliqua (ALQA): Stock Up 13.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 8:39AM CST
Alliqua, Inc. (ALQA) was a big mover last session, as the company saw its shares rise over 13% on the day.
ACOR: 36.14 (-0.51), ALQA: 6.14 (+0.09)
Nasdaq stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
UMPQ: 16.82 (+0.17), HBNK: 21.40 (+0.25), BRDR: 6.15 (+0.04), SAPE: 24.98 (-0.02), TAIT: 1.03 (+0.03), BASI: 2.06 (+0.18), GERN: 3.03 (unch), NYMX: 0.36 (-0.02), MTEX: 23.89 (+0.69), CKEC: 29.96 (+0.89), ALQA: 6.14 (+0.09)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 7.65 (+0.09), NEO: 4.10 (unch), AU: 12.33 (+0.36), FNHC: 29.64 (-0.29), AMS: 2.48 (+0.06), NYMX: 0.36 (-0.02), AMDA: 0.65 (+0.01), CVD: 107.08 (+0.05), GBIM: 7.85 (+0.25), RCAP: 10.28 (+0.28), KBIO: 0.45 (+0.06), COOL: 1.19 (unch), SAPE: 24.98 (-0.02), XTLB: 2.08 (-0.04), GERN: 3.03 (unch), ANIP: 62.69 (-0.43), BBLU: 1.26 (+0.09), NXTD: 2.70 (+0.04), AP: 18.27 (+0.09), ALQA: 6.14 (+0.09)
Alliqua's Biovance gets additional reimbursement code
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:54AM CST
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc.'s Biovance(R) Assigned Level II HCPCS Q Code for Product Reimbursement
GlobeNewswire - Mon Nov 03, 6:30AM CST
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced that Alliqua's Biovance(R) Human Amniotic Membrane Allograft, has been assigned a new and unique, Level II Healthcare Common Procedure Coding System (HCPCS) product reimbursement Q code (Q4154) by the Centers for Medicare and Medicaid Services ("CMS" . The new Q code assignment for Biovance is reflected in the Hospital Outpatient Prospective Payment System Final Rule for CY 2015, released by CMS on October 31, 2014. The new reimbursement code takes effect on January 1, 2015. ALQA: 6.14 (+0.09)
More on Alliqua BioMedical Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 4:16PM CDT
ALQA: 6.14 (+0.09)
Alliqua's (ALQA) CEO David Johnson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55PM CDT
ALQA: 6.14 (+0.09)
Alliqua misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:06PM CDT
ALQA: 6.14 (+0.09)
Alliqua BioMedical, Inc. Reports Third Quarter 2014 Financial Results
GlobeNewswire - Thu Oct 30, 3:49PM CDT
Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced financial results for the third quarter ended September 30, 2014. ALQA: 6.14 (+0.09)
